Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-04-22
2000-07-11
O'Sullivan, Peter
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
424499, 514 3, 514 12, 530399, A61K 2818
Patent
active
060873248
ABSTRACT:
According to a first embodiment, there is provided a sustained-release preparation comprising a water-insoluble or slightly water-soluble polyvalent metal salt of a water-soluble physiologically active substance which is not an endothelin antagonist, and a biodegradable polymer. The sustained-release preparation of the first embodiment is highly efficient in incorporating the water-soluble physiologically active substance and suppresses the initial burst of the water-soluble physiologically active substance. The sustained-release preparation of the present invention is capable of releasing the water-soluble physiologically active substance while retaining its bioactivity after administration in vivo. Furthermore, the water-soluble physiologically active substance in the sustained-release preparation is kept stable for a long period of time, with little loss of bioactivity.
According to a second embodiment, there is provided a sustained-release preparation comprising an anti-endothelin substance and a biodegradable polymer. The sustained-release preparation of the present invention sustainedly releases an anti-endothelin substance, serving well in the treatment of endothelin-associated diseases.
REFERENCES:
patent: 4853218 (1989-08-01), Yim et al.
patent: 5114918 (1992-05-01), Ishikawa et al.
patent: 5192741 (1993-03-01), Orsolini et al.
patent: 5270313 (1993-12-01), Burri et al.
patent: 5271945 (1993-12-01), Yoshioka et al.
patent: 5284828 (1994-02-01), Hemmi et al.
patent: 5292740 (1994-03-01), Burri et al.
patent: 5445832 (1995-08-01), Orsolini et al.
patent: 5510331 (1996-04-01), Hamon et al.
patent: 5643607 (1997-07-01), Okada et al.
patent: 5654010 (1997-08-01), Johnson et al.
patent: 5711968 (1998-01-01), Tracy et al.
Patent Abstract of JP 4-288099.
Lam et al., "Cochinmicins, Novel and Potent Cyclodepsipeptide Endothelin Antagonists from A Microbisphora sp. I. Production, Isolation and Characterization", The Journal of Antibiotics, vol. 45, No. 11, pp. 1709-1716, May 1992.
Zink et al., "Cochinmicins, Novel and Potent Cyclodepsipeptide Endothelin Antagonists from A Microbispora sp. II. Structure Determination", The Journal of Antibiotics, vol. 45, No. 11, pp. 1717-1722, May 1992.
U.S. Patent application No. 071 984,323of Henry Auer, et al., Controlled Released Growth Hormone Containing Microspheres, Filed Dec. 2, 1992.
Igari Yasutaka
Yamagata Yutaka
O'Sullivan Peter
Takeda Chemical Industries Ltd.
LandOfFree
Sustained-release preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sustained-release preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained-release preparation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-542403